Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Tirofiban hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tirofiban hydrochloride and what is the scope of tirofiban hydrochloride freedom to operate?

Tirofiban hydrochloride
is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tirofiban hydrochloride has fifty-nine patent family members in thirty-five countries.

There are three drug master file entries for tirofiban hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: tirofiban hydrochloride

Tradenames:1
Patents:6
Applicants:1
NDAs:2
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list89
Clinical Trials: see list1,004
Patent Applications: see list6,092
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tirofiban hydrochloride at DailyMed

Pharmacology for Ingredient: tirofiban hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicure
AGGRASTAT
tirofiban hydrochloride
SOLUTION;INJECTION020912-002Aug 31, 2016RXYesYes5,733,919► SubscribeY ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020912-001May 14, 1998DISCNNoNo5,978,698► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-003Apr 20, 2000RXYesYes6,770,660► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 2002RXYesNo5,733,919► Subscribe ► Subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-001May 14, 1998DISCNNoNo5,733,919► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot